Volume | 202,750 |
|
|||||
News | - | ||||||
Day High | 1.48 | Low High |
|||||
Day Low | 1.35 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Clearside Biomedical Inc | CLSD | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
1.43 | 1.35 | 1.48 | 1.41 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
527 | 202,750 | $ 1.44 | $ 291,483 | - | 0.650101 - 2.12 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
14:15:06 | 38 | $ 1.39 | USD |
Clearside Biomedical Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
108.35M | 74.72M | - | 8.23M | -32.49M | -0.43 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Clearside Biomedical News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CLSD Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.24 | 1.48 | 1.10 | 1.29 | 292,731 | 0.12 | 9.68% |
1 Month | 1.71 | 1.76 | 1.10 | 1.38 | 312,194 | -0.35 | -20.47% |
3 Months | 1.31 | 2.12 | 1.10 | 1.55 | 382,092 | 0.05 | 3.82% |
6 Months | 0.79 | 2.12 | 0.650101 | 1.39 | 283,586 | 0.57 | 72.15% |
1 Year | 1.06 | 2.12 | 0.650101 | 1.30 | 197,782 | 0.30 | 28.30% |
3 Years | 2.94 | 7.73 | 0.650101 | 3.42 | 559,869 | -1.58 | -53.74% |
5 Years | 1.23 | 7.73 | 0.56 | 2.84 | 584,780 | 0.13 | 10.57% |
Clearside Biomedical Description
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye. The product candidates of the company focus on a disease affecting the retina and aim to restore or improve visual function primarily by reducing the macular edema associated with several diseases affecting vision. |